Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-19-001379
Filing Date
2019-06-11
Accepted
2019-06-11 14:57:17
Documents
1
Period of Report
2019-06-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 2934
  Complete submission text file 0001593968-19-001379.txt   4296
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address
Kunz Barbara Lopez (Reporting) CIK: 0001679970 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37746 | Film No.: 19890772